MA28739B1 - Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer - Google Patents
Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancerInfo
- Publication number
- MA28739B1 MA28739B1 MA29617A MA29617A MA28739B1 MA 28739 B1 MA28739 B1 MA 28739B1 MA 29617 A MA29617 A MA 29617A MA 29617 A MA29617 A MA 29617A MA 28739 B1 MA28739 B1 MA 28739B1
- Authority
- MA
- Morocco
- Prior art keywords
- dymethylpropyl
- ksp
- imidazol
- fungal
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58092704P | 2004-06-18 | 2004-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA28739B1 true MA28739B1 (fr) | 2007-07-02 |
Family
ID=34980173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29617A MA28739B1 (fr) | 2004-06-18 | 2007-01-17 | Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer |
Country Status (21)
Country | Link |
---|---|
US (3) | US7576221B2 (fr) |
EP (1) | EP1765789B1 (fr) |
JP (2) | JP4836280B2 (fr) |
KR (1) | KR101170925B1 (fr) |
CN (1) | CN1993331A (fr) |
AU (1) | AU2005258135B2 (fr) |
BR (1) | BRPI0510929A (fr) |
CA (1) | CA2571002A1 (fr) |
EC (1) | ECSP077183A (fr) |
ES (1) | ES2409345T3 (fr) |
IL (1) | IL180147A0 (fr) |
MA (1) | MA28739B1 (fr) |
MX (1) | MXPA06014909A (fr) |
NO (1) | NO20070343L (fr) |
NZ (1) | NZ552510A (fr) |
RU (1) | RU2427572C2 (fr) |
SG (1) | SG153851A1 (fr) |
TN (1) | TNSN06419A1 (fr) |
TW (1) | TW200612958A (fr) |
WO (1) | WO2006002236A1 (fr) |
ZA (1) | ZA200700481B (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06014909A (es) * | 2004-06-18 | 2007-02-28 | Chiron Corp | Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer. |
UA89201C2 (ru) | 2004-08-18 | 2010-01-11 | Астразенека Аб | Энантиомеры выбранных конденсированных пиримидонов и их применение для лечения и профилактики злокачественного новообразования |
WO2007011647A2 (fr) * | 2005-07-15 | 2007-01-25 | Kalypsys, Inc. | Inhibiteurs de la kinesine mitotique |
MY147188A (en) * | 2005-08-09 | 2012-11-14 | Novartis Ag | Substituted imidazole compounds as ksp inhibitors |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
US7553854B2 (en) | 2006-04-19 | 2009-06-30 | Novartis Vaccines And Diagnostics, Inc. | 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
WO2008029825A1 (fr) | 2006-09-05 | 2008-03-13 | Kyowa Hakko Kirin Co., Ltd. | Dérivé d'imidazole |
EA200970361A1 (ru) | 2006-10-09 | 2010-02-26 | Такеда Фармасьютикал Компани Лимитед | Ингибиторы киназы |
US7902240B2 (en) * | 2006-11-13 | 2011-03-08 | Novartis Ag | Substituted pyrazole and triazole compounds as KSP inhibitors |
WO2008086122A2 (fr) * | 2007-01-05 | 2008-07-17 | Novartis Ag | Dérivés cyclisés en tant qu'inhibiteurs d'eg-5 |
US8252832B2 (en) | 2007-12-14 | 2012-08-28 | Novartis Ag | Kinesin inhibitors as cancer therapeutics |
EP2389363A1 (fr) | 2009-01-26 | 2011-11-30 | Novartis AG | Sels et polymorphes d'un composé inhibiteur de la kinésine |
AU2011239977B2 (en) | 2010-04-15 | 2014-11-27 | Novartis Ag | Triazole compounds as KSP inhibitors |
WO2011128388A2 (fr) * | 2010-04-15 | 2011-10-20 | Novartis Ag | Composés d'oxazole et de thiazole comme inhibiteurs de ksp |
DE102010025663A1 (de) | 2010-06-30 | 2012-01-05 | Karl-Heinz Glüsenkamp | Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate |
US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
US9498540B2 (en) | 2013-03-15 | 2016-11-22 | Novartis Ag | Cell proliferation inhibitors and conjugates thereof |
WO2014151030A1 (fr) * | 2013-03-15 | 2014-09-25 | Novartis Ag | Inhibiteurs de la prolifération cellulaire et leurs conjugués |
WO2015096982A1 (fr) * | 2013-12-23 | 2015-07-02 | Bayer Pharma Aktiengesellschaft | Conjugués de liant (conjugué anticorps-médicament) comprenant des inhibiteurs de la protéine kinésine du fuseau |
WO2016020791A1 (fr) | 2014-08-05 | 2016-02-11 | Novartis Ag | Conjugués anticorps ckit-médicament |
JP6743015B2 (ja) | 2014-12-15 | 2020-08-19 | バイエル ファーマ アクチエンゲゼルシャフト | Ksp阻害剤の脱グリコシル化抗tweakr抗体との抗体薬物複合体(adc類) |
IS2977B (is) | 2015-02-23 | 2017-07-15 | Actavis Group Ptc Ehf. | Aðferð til framleiðslu á milliefnum sem eru nytsamleg við nýsmíði á elúxadólíni |
CN108025084B (zh) | 2015-06-22 | 2024-08-09 | 拜耳医药股份有限公司 | 具有酶可裂解基团的抗体药物缀合物(adc)和抗体前药缀合物(apdc) |
CN107921288A (zh) | 2015-06-23 | 2018-04-17 | 拜耳医药股份有限公司 | Ksp抑制剂的靶向缀合物 |
US20180318438A1 (en) | 2015-06-23 | 2018-11-08 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates of kinesin spindel protein (ksp) inhibitors with anti-tweakr-antibodies |
CN108025086A (zh) | 2015-06-23 | 2018-05-11 | 拜耳制药股份公司 | Ksp抑制剂与抗b7h3抗体的抗体-活性物质缀合物(adc) |
EP3471776B1 (fr) | 2016-06-15 | 2022-05-04 | Bayer Pharma Aktiengesellschaft | Conjugués anticorps-médicament spécifiques avec inhibiteurs de ksp et des anticorps anti-cd123 |
EP3558388A1 (fr) | 2016-12-21 | 2019-10-30 | Bayer Pharma Aktiengesellschaft | Conjugués liant-principe actif (adc) ayant des groupes enzymatiquement clivables |
CA3047522A1 (fr) | 2016-12-21 | 2018-06-28 | Bayer Pharma Aktiengesellschaft | Conjugues anticorps-principe actif (adc) specifiques renfermant des inhibiteurs de ksp |
EP3806908A1 (fr) | 2018-06-18 | 2021-04-21 | Bayer Aktiengesellschaft | Conjugués liant-principe actif inhibant cxcr5 comprenant des éléments de liaison pouvant être fragmentés de manière enzymatique et présentant un profil d'action amélioré |
MA54543A (fr) | 2018-12-20 | 2022-03-30 | Amgen Inc | Inhibiteurs de kif18a |
CA3230123A1 (fr) | 2021-08-26 | 2023-03-02 | Derek A. Cogan | Inhibiteurs spiro-indoliniques de la kif18a |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2550959C3 (de) * | 1975-11-13 | 1980-12-04 | Hoechst Ag, 6000 Frankfurt | Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
WO1998027108A2 (fr) | 1996-12-16 | 1998-06-25 | Fujisawa Pharmaceutical Co., Ltd. | Nouveaux composes amide |
US6117940A (en) | 1997-10-17 | 2000-09-12 | Mjalli; Adnan M. M. | Amino-ketone solid support templates |
ES2211172T3 (es) | 1998-09-25 | 2004-07-01 | Astrazeneca Ab | Derivados de benzamida y su utilizacion como inhibidores de citoquinas. |
JP2002541146A (ja) | 1999-04-02 | 2002-12-03 | ニューロゲン コーポレイション | アリールおよびヘテロアリール融合のアミノアルキル−イミダゾール誘導体および糖尿病薬としてのその使用 |
TWI283577B (en) * | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
US7291641B2 (en) * | 1999-10-11 | 2007-11-06 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
US20040132788A1 (en) | 1999-10-11 | 2004-07-08 | Chabrier De Lassauniere Pierre-Etienne | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
KR20020062930A (ko) | 1999-10-27 | 2002-07-31 | 싸이토키네틱스, 인코포레이티드 | 퀴나졸리논을 사용하는 방법 및 조성물 |
WO2001083575A1 (fr) | 2000-05-02 | 2001-11-08 | Advanced Syntech, Llc A Kentucky Limited Liability Corporation | Nouvelle matrice de support solide destinee a la preparation de composes heterocycles a haute fonctionnalite |
US6683191B2 (en) * | 2000-06-05 | 2004-01-27 | Ortho-Mcneil Pharmaceuticals, Inc. | Method for synthesis of substituted azole libraries |
US6951948B2 (en) * | 2000-06-05 | 2005-10-04 | Ortho-Mcneil Pharmaceutical, Inc. | Method for synthesis of substituted azole libraries |
WO2002010140A2 (fr) | 2000-08-01 | 2002-02-07 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Dérivés imidazolyles |
CA2425185A1 (fr) | 2000-10-06 | 2002-04-11 | Stephane De Lombaert | Derives de benzimidazole et d'indole en tant que modulateurs des recepteurs de la corticoliberine |
JP2002190437A (ja) | 2000-12-20 | 2002-07-05 | Advantest Corp | 電子ビーム露光装置及び校正方法 |
EP1351671A1 (fr) | 2001-01-19 | 2003-10-15 | Cytokinetics, Inc. | Inhibiteurs triphenylmethane de la kinesine |
EP1360180A1 (fr) | 2001-01-19 | 2003-11-12 | Cytokinetics, Inc. | Inhibiteurs de la kinesine a base de phenothiazine |
US6610723B2 (en) * | 2001-01-29 | 2003-08-26 | Hoffmann-La Roche Inc. | Imidazole derivatives |
CA2465491A1 (fr) | 2001-11-07 | 2003-05-15 | Merck & Co., Inc. | Inhibiteurs de la kinesine mitotique |
US7049303B2 (en) | 2001-11-07 | 2006-05-23 | Medical Research Council | Inhibition of viruses |
US6753428B2 (en) | 2001-11-20 | 2004-06-22 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
ATE424388T1 (de) | 2001-12-06 | 2009-03-15 | Merck & Co Inc | Mitotische kinesinhemmer |
US7262186B2 (en) | 2001-12-06 | 2007-08-28 | Merck & Co., Inc. | Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor |
AU2002364128B2 (en) | 2001-12-06 | 2008-03-06 | Merck Sharp & Dohme Corp. | Mitotic kinesin inhibitors |
ATE447577T1 (de) * | 2001-12-06 | 2009-11-15 | Merck & Co Inc | Mitotische kinesin-hemmer |
DE60222302T2 (de) | 2001-12-06 | 2008-05-29 | Merck & Co., Inc. | Inhibitoren von mitotischem kinesin |
EP1465888A2 (fr) | 2002-01-10 | 2004-10-13 | Neurogen Corporation | Ligands recepteurs de l'hormone de concentration de la melanine: analogues de benzoimidazole substitue |
US7009049B2 (en) | 2002-02-15 | 2006-03-07 | Cytokinetics, Inc. | Syntheses of quinazolinones |
JP4399269B2 (ja) | 2002-03-08 | 2010-01-13 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂性キネシン阻害薬 |
DE10211770A1 (de) | 2002-03-14 | 2003-10-02 | Boehringer Ingelheim Pharma | Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US7026312B2 (en) | 2002-03-14 | 2006-04-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
AU2003245259A1 (en) * | 2002-05-02 | 2003-11-17 | Neurogen Corporation | Substituted imidazole derivatives: gabaa receptor ligands |
EP1501825A2 (fr) * | 2002-05-08 | 2005-02-02 | Neurogen Corporation | Imidazolylmethyl pyridine substituee et derives de pyrazine: les ligands des recepteurs gaba a |
WO2003097053A1 (fr) | 2002-05-09 | 2003-11-27 | Cytokinetics, Inc. | Composes, compositions et procedes |
JP2006508030A (ja) * | 2002-05-09 | 2006-03-09 | サイトキネティクス・インコーポレーテッド | ピリミジノン化合物、組成物および方法 |
US20040053948A1 (en) | 2002-05-10 | 2004-03-18 | Cytokinetics, Inc. | Compounds, compositions and methods |
CA2486339A1 (fr) * | 2002-05-17 | 2003-11-27 | Neurogen Corporation | Derives d'imidazole a cycles fusionnes se fixant aux recepteurs gaba<sb>a</sb>, ligands des recepteurs gaba<sb>a</sb> |
WO2003103575A2 (fr) * | 2002-05-23 | 2003-12-18 | Cytokinetics, Inc. | Composes, compositions et procedes |
CA2483627A1 (fr) | 2002-05-23 | 2003-12-04 | Merck & Co., Inc. | Inhibiteurs de kinesine mitotique |
US7301028B2 (en) | 2002-06-14 | 2007-11-27 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
MXPA04012642A (es) | 2002-06-14 | 2005-03-23 | Merck & Co Inc | Inhibidores de la cinesina mitotica. |
WO2004001489A1 (fr) | 2002-06-19 | 2003-12-31 | Mitsubishi Denki Kabushiki Kaisha | Modulateur de lumiere |
JP2005537257A (ja) | 2002-07-08 | 2005-12-08 | メルク エンド カムパニー インコーポレーテッド | 有糸分裂キネシン結合部位 |
RU2233736C2 (ru) | 2002-07-11 | 2004-08-10 | Раховский Вадим Израилович | Нанометрическое позиционирующее устройство |
EP1539727B1 (fr) | 2002-07-17 | 2009-02-18 | Cytokinetics, Inc. | Composes, compositions et methodes pour le traitement des maladies proliferatives cellulaires |
EP1537089A4 (fr) | 2002-07-23 | 2008-04-16 | Cytokinetics Inc | Composes, compositions et procedes |
KR100492252B1 (ko) | 2002-08-09 | 2005-05-30 | 한국화학연구원 | 이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법 |
JP2005536553A (ja) | 2002-08-21 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
JP2005539062A (ja) | 2002-09-13 | 2005-12-22 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
DE60328028D1 (de) * | 2002-09-18 | 2009-07-30 | Pfizer Prod Inc | Imidazolverbindungen als inhibitoren des transformierenden wachstumsfaktors (twf) |
US7557115B2 (en) * | 2002-09-30 | 2009-07-07 | Cytokinetics, Inc. | Compounds, compositions, and methods |
CN100579579C (zh) * | 2002-10-01 | 2010-01-13 | 诺华疫苗和诊断公司 | 抗癌及抗感染性疾病组合物及其使用方法 |
PL375889A1 (en) * | 2002-10-11 | 2005-12-12 | Cytokinetics, Inc. | Compounds for treating cellular proliferative diseases, compositions containing them and their application |
EP1560822B1 (fr) * | 2002-11-08 | 2006-08-09 | Neurogen Corporation | Derives de 4-imidazol-1-ylmethyl-pyrimidine en tant que ligands de recepteurs gabaa |
US20040186151A1 (en) | 2003-02-12 | 2004-09-23 | Mjalli Adnan M.M. | Substituted azole derivatives as therapeutic agents |
US7662581B1 (en) * | 2003-12-18 | 2010-02-16 | Novartis Vaccines And Diagnostics, Inc. | Eg5 co-crystals |
CA2552558A1 (fr) | 2004-01-16 | 2005-08-11 | Wyeth | Inhibiteurs a base de sulfonamides heterocycliques de la production des beta-amyloides contenant un azole |
EP1730118A1 (fr) * | 2004-02-12 | 2006-12-13 | Transtech Pharma, Inc. | Derives d'azole substitues, compositions, et procedes d'utilisation |
CA2561904A1 (fr) * | 2004-04-06 | 2005-10-27 | Chiron Corporation | Inhibiteurs de la kinesine mitotique |
WO2005100322A1 (fr) | 2004-04-14 | 2005-10-27 | Pfizer Limited | Composes d'imidazole a liaison souphre pour le traitement du vih |
TW200540155A (en) | 2004-04-28 | 2005-12-16 | Takeda Pharmaceutical | Fused quinoline derivative and use thereof |
US7618981B2 (en) | 2004-05-06 | 2009-11-17 | Cytokinetics, Inc. | Imidazopyridinyl-benzamide anti-cancer agents |
MXPA06014909A (es) * | 2004-06-18 | 2007-02-28 | Chiron Corp | Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer. |
-
2005
- 2005-06-20 MX MXPA06014909A patent/MXPA06014909A/es active IP Right Grant
- 2005-06-20 US US11/158,574 patent/US7576221B2/en not_active Expired - Fee Related
- 2005-06-20 KR KR1020077000979A patent/KR101170925B1/ko not_active IP Right Cessation
- 2005-06-20 WO PCT/US2005/022062 patent/WO2006002236A1/fr active Application Filing
- 2005-06-20 EP EP05760871A patent/EP1765789B1/fr not_active Not-in-force
- 2005-06-20 CN CNA2005800262037A patent/CN1993331A/zh active Pending
- 2005-06-20 JP JP2007516842A patent/JP4836280B2/ja not_active Expired - Fee Related
- 2005-06-20 CA CA002571002A patent/CA2571002A1/fr not_active Abandoned
- 2005-06-20 AU AU2005258135A patent/AU2005258135B2/en not_active Ceased
- 2005-06-20 ES ES05760871T patent/ES2409345T3/es active Active
- 2005-06-20 NZ NZ552510A patent/NZ552510A/en not_active IP Right Cessation
- 2005-06-20 BR BRPI0510929-9A patent/BRPI0510929A/pt not_active IP Right Cessation
- 2005-06-20 RU RU2007101612/04A patent/RU2427572C2/ru not_active IP Right Cessation
- 2005-06-20 TW TW094120475A patent/TW200612958A/zh unknown
- 2005-06-20 SG SG200904294-6A patent/SG153851A1/en unknown
-
2006
- 2006-12-18 TN TNP2006000419A patent/TNSN06419A1/en unknown
- 2006-12-18 IL IL180147A patent/IL180147A0/en unknown
-
2007
- 2007-01-16 ZA ZA200700481A patent/ZA200700481B/xx unknown
- 2007-01-17 MA MA29617A patent/MA28739B1/fr unknown
- 2007-01-18 NO NO20070343A patent/NO20070343L/no not_active Application Discontinuation
- 2007-01-18 EC EC2007007183A patent/ECSP077183A/es unknown
-
2009
- 2009-06-05 US US12/455,798 patent/US8318791B2/en not_active Expired - Fee Related
-
2011
- 2011-08-18 JP JP2011179247A patent/JP2011256197A/ja not_active Withdrawn
-
2012
- 2012-09-13 US US13/613,977 patent/US8735599B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1993331A (zh) | 2007-07-04 |
RU2007101612A (ru) | 2008-08-10 |
EP1765789A1 (fr) | 2007-03-28 |
US8318791B2 (en) | 2012-11-27 |
US8735599B2 (en) | 2014-05-27 |
US20060009472A1 (en) | 2006-01-12 |
AU2005258135A1 (en) | 2006-01-05 |
US20130017196A1 (en) | 2013-01-17 |
CA2571002A1 (fr) | 2006-01-05 |
SG153851A1 (en) | 2009-07-29 |
TW200612958A (en) | 2006-05-01 |
KR20070106961A (ko) | 2007-11-06 |
WO2006002236A1 (fr) | 2006-01-05 |
NZ552510A (en) | 2010-12-24 |
KR101170925B1 (ko) | 2012-08-07 |
AU2005258135B2 (en) | 2011-09-22 |
ECSP077183A (es) | 2007-02-28 |
ES2409345T3 (es) | 2013-06-26 |
NO20070343L (no) | 2007-03-05 |
JP4836280B2 (ja) | 2011-12-14 |
TNSN06419A1 (en) | 2008-02-22 |
RU2427572C2 (ru) | 2011-08-27 |
MXPA06014909A (es) | 2007-02-28 |
ZA200700481B (en) | 2008-10-29 |
JP2008503501A (ja) | 2008-02-07 |
US7576221B2 (en) | 2009-08-18 |
JP2011256197A (ja) | 2011-12-22 |
IL180147A0 (en) | 2007-06-03 |
US20090258016A1 (en) | 2009-10-15 |
BRPI0510929A (pt) | 2007-07-17 |
EP1765789B1 (fr) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA28739B1 (fr) | Derives de n-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dymethylpropyl) benzamide et composes associes comme inhibiteurs de la proteine kinesine fuseau (ksp) pour le traitement du cancer | |
MA28365A1 (fr) | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah | |
MA27230A1 (fr) | Derives d'aminoindazoles comme inhibiteurs de proteines-kinase | |
WO2004089286A3 (fr) | Nouveaux composes et compositions utilises comme inhibiteurs de la proteine kinase | |
EA200602241A1 (ru) | Замещённые индазолы, композиции, содержащие указанные индазолы, способ их получения и применение | |
DK1318992T3 (da) | Imidazolderivater som Raf-kinaseinhibitorer | |
MA28822B1 (fr) | Benzamides substitues trifluoromethyle comme inhibiteurs de kinase | |
DE60332604D1 (de) | Azolylaminoazine als proteinkinasehemmer | |
NO20070514L (no) | Pyrrolotriazin kinase inhibitorer | |
WO2011046964A3 (fr) | Inhibiteurs de tyrosine kinase de bruton | |
WO2007115289A8 (fr) | Combinaisons d'agents thérapeutiques destinées à traiter le cancer | |
ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
ATE536353T1 (de) | 2-(4-amino-1,2,5-oxadiazol-4-yl)-imidazol- verbindungen als protein kinase inhibitoren | |
WO2008098104A8 (fr) | Inhibiteurs de l'activité de akt | |
ATE482213T1 (de) | Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine | |
IL176478A0 (en) | Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme | |
ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
MA28279A1 (fr) | Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2 | |
DE602005012481D1 (de) | 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck | |
BRPI0518228B8 (pt) | inibidores de cinesina mitótica e uso dos mesmos | |
FR2880540B1 (fr) | Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90 | |
NO20052751D0 (no) | Oftalmisk preparat for behandling av okulaer hypertensjon. | |
DK2054418T3 (da) | Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer | |
MA28941B1 (fr) | Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |